One could theorize a protocol where GHK-Cu is used to create a pro-regenerative systemic environment, followed by the application of KLOW to direct that potential towards a specific tissue
Published Research GHK-Cu Gene Expression Pickart et al
Toosy AT, Mason DF, Miller DH
BPC-157 / TB-500 is a research peptide blend combining two well-studied synthetic peptides: Body Protection Compound-157 (BPC-157) and Thymosin Beta-4 fragment TB-500. BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, while TB-500 is a synthetic peptide modeled after the naturally occurring thymosin beta-4. Together, this blend is formulated for laboratory research focused on tissue repair, angiogenesis, and cellular regeneration pathways
On the other hand, peptides play a crucial role in maintaining skin health
In addition, TB-500 represents a marketed formulation rather than a standardized pharmaceutical product, introducing uncertainty regarding composition, dosing equivalence, and biologic predictability (Rahman et al